Stock listing
Neuphoria Therapeutics Inc.
Selected listing: NEUP · NASDAQ · USD · US
Neuphoria Therapeutics Inc. (NASDAQ:NEUP), Health Technology. Latest release Jul 23, 2026: Scancell and Neuphoria Therapeutics Announce Merger Agreement…
- Ticker
- NASDAQ:NEUP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Neuphoria Therapeutics Inc.
The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and market performance on the 6ix platform.
Latest news from Neuphoria Therapeutics Inc.
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
July 22, 2026
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
June 26, 2026
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
December 8, 2025
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
December 4, 2025
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders
December 2, 2025
Research Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. company profile
View the public company page for Neuphoria Therapeutics Inc. on 6ix.
Neuphoria Therapeutics Inc. news
Read company news and market updates connected to Neuphoria Therapeutics Inc..
Neuphoria Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Neuphoria Therapeutics Inc..